Thomas Kaufmann

22PUBLICATIONS
47CO-AUTHORS
Molecular targetsAllergyChemotherapyHaematologyAnimal protection (incl. pests and pathogens)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 29, 2026
Dual targeting of BCL-XL and MCL-1 exposes a rapid and exploitable apoptotic vulnerability in non-small cell lung cancer.

|Jan 29, 2026
Loss of BOK increases vulnerability of p53 deficient non-small cell lung cancer cells to ATR inhibition through its role in uridine metabolism.

Philippe JeanRichard, Aparna Ananthanarayan, Liyang Wu

|Oct 24, 2025
Large transient assemblies of Apaf1 constitute the apoptosome in cells.

Alicia C Borgeaud, Iva Ganeva, Calvin Klein

|Sep 28, 2024
Clinical utility analysis of the Hoxb8 mast cell activation test for the diagnosis of peanut allergy.

Noemi Bachmeier-Zbären, Alper Celik, Robin van Brummelen

|Nov 24, 2023
Non-canonical BIM-regulated energy metabolism determines drug-induced liver necrosis.

Rebekka Lambrecht, Franziska Rudolf, Anna-Katharina Ückert

|May 10, 2022
Hexokinase 3 enhances myeloid cell survival via non-glycolytic functions.

Kristina Seiler, Magali Humbert, Petra Minder

Pageof 4

Frequent Collaborators

4 joint publications

Philipp J Jost

3 joint publications

Wendy Wei-Lynn Wong

3 joint publications

Liyang Wu

2 joint publications

Mario P Tschan